Literature DB >> 18986225

Segmental neuropathic pain does not develop in male rats with complete spinal transections.

Charles H Hubscher1, Ezidin G Kaddumi, Richard D Johnson.   

Abstract

In a previous study using male rats, a correlation was found between the development of "at-level" allodynia in T6-7 dermatomes following severe T8 spinal contusion injury and the sparing of some myelinated axons within the core of the lesion epicenter. To further test our hypothesis that this sparing is important for the expression of allodynia and the supraspinal plasticity that ensues, an injury that severs all axons (i.e., a complete spinal cord transection) was made in 15 male rats. Behavioral assessments were done at level throughout the 30-day recovery period followed by terminal electrophysiological recordings (urethane anesthesia) from single medullary reticular formation (MRF) neurons receiving convergent nociceptive inputs from receptive fields above, at, and below the lesion level. None of the rats developed signs of at-level allodynia (versus 18 of 26 male rats following severe contusion). However, the terminal recording (206 MRF neurons) data resembled those obtained previously post-contusion. That is, there was evidence of neuronal hyper-excitability (relative to previous data from intact controls) to high- and low-threshold mechanical stimulation for "at-level" (dorsal trunk) and "above-level" (eyelids and face) cutaneous territories. These results, when combined with prior data on intact controls and severe/moderate contusions, indicate that (1) an anatomically incomplete injury (some lesion epicenter axonal sparing) following severe contusion is likely important for the development of allodynia and (2) the neuronal hyper-excitability at the level of the medulla is likely involved in nociceptive processes that are not directly related to the conscious expression of pain-like avoidance behaviors that are being used as evidence of allodynia.

Entities:  

Mesh:

Year:  2008        PMID: 18986225      PMCID: PMC2742354          DOI: 10.1089/neu.2008.0515

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  31 in total

1.  Lumbar transplants of immortalized serotonergic neurons alleviate chronic neuropathic pain.

Authors:  M J Eaton; D I Santiago; H A Dancausse; S R Whittemore
Journal:  Pain       Date:  1997-08       Impact factor: 6.961

2.  Chronic spinal cord injury induced changes in the responses of thalamic neurons.

Authors:  Charles H Hubscher; Richard D Johnson
Journal:  Exp Neurol       Date:  2005-11-02       Impact factor: 5.330

3.  Bilateral chronic constriction of the sciatic nerve: a model of long-term cold hyperalgesia.

Authors:  Charles J Vierck; Antonio J Acosta-Rua; Richard D Johnson
Journal:  J Pain       Date:  2005-08       Impact factor: 5.820

4.  Spinal cord injury triggers sensitization of wide dynamic range dorsal horn neurons in segments rostral to the injury.

Authors:  Haijun Zhang; Wenrui Xie; Yikuan Xie
Journal:  Brain Res       Date:  2005-09-07       Impact factor: 3.252

5.  Changes in neuronal receptive field characteristics in caudal brain stem following chronic spinal cord injury.

Authors:  C H Hubscher; R D Johnson
Journal:  J Neurotrauma       Date:  1999-06       Impact factor: 5.269

6.  Secondary conditions following spinal cord injury in a population-based sample.

Authors:  R L Johnson; K A Gerhart; J McCray; J C Menconi; G G Whiteneck
Journal:  Spinal Cord       Date:  1998-01       Impact factor: 2.772

7.  Targeting recovery: priorities of the spinal cord-injured population.

Authors:  Kim D Anderson
Journal:  J Neurotrauma       Date:  2004-10       Impact factor: 5.269

8.  Effects of acute and chronic midthoracic spinal cord injury on neural circuits for male sexual function. I. Ascending pathways.

Authors:  C H Hubscher; R D Johnson
Journal:  J Neurophysiol       Date:  1999-09       Impact factor: 2.714

9.  Upregulation of the phosphorylated form of CREB in spinothalamic tract cells following spinal cord injury: relation to central neuropathic pain.

Authors:  E D Crown; Z Ye; K M Johnson; G-Y Xu; D J McAdoo; K N Westlund; C E Hulsebosch
Journal:  Neurosci Lett       Date:  2005 Aug 12-19       Impact factor: 3.046

10.  Neuropathic pain after traumatic spinal cord injury--relations to gender, spinal level, completeness, and age at the time of injury.

Authors:  L Werhagen; C N Budh; C Hultling; C Molander
Journal:  Spinal Cord       Date:  2004-12       Impact factor: 2.772

View more
  6 in total

1.  Spinal cord injuries containing asymmetrical damage in the ventrolateral funiculus is associated with a higher incidence of at-level allodynia.

Authors:  Bradley J Hall; Jason E Lally; Eric V Vukmanic; James E Armstrong; Jason D Fell; Daya S Gupta; Charles H Hubscher
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

2.  Sex and hormonal variations in the development of at-level allodynia in a rat chronic spinal cord injury model.

Authors:  Charles H Hubscher; Jason D Fell; Daya S Gupta
Journal:  Neurosci Lett       Date:  2010-04-29       Impact factor: 3.046

3.  Morphine self-administration following spinal cord injury.

Authors:  Sarah A Woller; Jamal S Malik; Miriam Aceves; Michelle A Hook
Journal:  J Neurotrauma       Date:  2014-07-24       Impact factor: 5.269

Review 4.  The animal model of spinal cord injury as an experimental pain model.

Authors:  Aya Nakae; Kunihiro Nakai; Kenji Yano; Ko Hosokawa; Masahiko Shibata; Takashi Mashimo
Journal:  J Biomed Biotechnol       Date:  2011-03-07

5.  Estradiol treatment prevents injury induced enhancement in spinal cord dynorphin expression.

Authors:  Daya S Gupta; Charles H Hubscher
Journal:  Front Physiol       Date:  2012-02-22       Impact factor: 4.566

6.  Spinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterization.

Authors:  Saïd M'Dahoma; Sylvie Bourgoin; Valérie Kayser; Sandrine Barthélémy; Caroline Chevarin; Farah Chali; Didier Orsal; Michel Hamon
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.